Comparison of tumor mutational burden across eight types of human cancer.

被引：0
作者：
Chen, Peng
Zhang, Cuicui
Meng, Zhaoting
Zhang, Xing
Ge, Minhui
Qin, Huijuan
机构：
[1] Tianjin Med Univ Canc Inst & Hosp, Dept Thorac Oncol, Tianjin, Peoples R China
[2] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15170
引用
收藏
页数：1
相关论文
共 50 条
[41]   Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types [J].
Kamath, Suneel D. ;
Kircher, Sheetal M. ;
Benson, Al B., III .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (07) :849-+
[42]   Blood-based tumor mutational burden from circulating tumor DNA and immune checkpoint inhibitors in advanced prostate cancer. [J].
Rauterkus, Grant ;
Hadadi, Agreen ;
Barnett, Reagan ;
Weipert, Caroline ;
Drusbosky, Leylah ;
Gao, Xin ;
Lilly, Michael B. ;
Bryce, Alan Haruo ;
Naqvi, Syed Arsalan Ahmed ;
Barata, Pedro C. ;
Bilen, Mehmet Asim .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[43]   Determinants of high tumor mutational burden (TMB) and mutational signatures in breast cancer [J].
Barroso-Sousa, Romualdo ;
Jain, Esha ;
Kim, Dewey ;
Partridge, Ann H. ;
Cohen, Ofir ;
Wagle, Nikhil .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[44]   Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types (vol 13, e010311, 2025) [J].
Gandara, David R. ;
Agarwal, Neeraj ;
Gupta, Shilpa ;
Klempner, Samuel J. ;
Andrews, Miles C. ;
Mahipal, Amit ;
Subbiah, Vivek ;
Eskander, Ramez N. ;
Carbone, David P. ;
Riess, Jonathan W. ;
Sammons, Sarah ;
Snider, Jeremy ;
Bouzit, Lilia ;
Cho-Phan, Cheryl ;
Price, Megan ;
Li, Gerald ;
Quintanilha, Julia C. F. ;
Huang, Richard Sheng Poe ;
Ross, Jeffrey S. ;
Fabrizio, David ;
Oxnard, Geoffrey R. ;
Graf, Ryon P. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
[45]   Distributional range of tumor mutational burden (TMB) across multiple cancer types emphasizing the importance of different cutoff values in different tumor types for clinical interpretation: A consensus statement from the SEQUOIA consortium [J].
Swat, Wojciech ;
Kumar, Dibyendu ;
Boyle, Theresa A. ;
Dalton, Emily ;
Comer, Stewart ;
Solomon, James ;
Golem, Shivani ;
Eyring, Kenneth R. ;
Baskovich, Brett ;
Vashisht, Ashutosh ;
Singh, Harmanpreet ;
Ahluwalia, Pankaj Kumar ;
Alptekin, Ahmet ;
Sahajpal, Nikhil ;
Mondal, Ashis ;
Kota, Vamsi ;
Kolhe, Ravindra .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[46]   Association of alterations in DNA damage repair and Notch pathways with high tumor mutational burden in patients with cervical cancer. [J].
Zou, Dongling ;
Li, Zirong ;
Liu, Jing ;
Gao, Yunong ;
Zheng, Hong ;
Yuan, Mingming ;
Wang, Haixia ;
Yuan, Li ;
Wang, Dong ;
Liu, Jingshu ;
Chen, Rongrong ;
Xia, Xuefeng ;
Zhou, Qi .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[47]   Correlation of exploration of immune profile and genomic with microsatellite stable/tumor mutational burden-low colorectal cancer. [J].
Abushukair, Hassan Mohammed ;
Saeed, Azhar ;
Sahin, Ibrahim Halil ;
Saeed, Anwaar .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) :213-213
[48]   Comparison of tumor mutational burden (TMB) in relevant molecular subsets of metastatic urothelial cancer (MUC) [J].
Pal, S. K. ;
Agarwal, N. ;
Choueiri, T. K. ;
Stephens, P. J. ;
Ross, J. S. ;
Miller, V. A. ;
Ali, S. M. ;
Chung, J. ;
Grivas, P. .
ANNALS OF ONCOLOGY, 2017, 28
[49]   Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration [J].
Hu-Lieskovan, Siwen ;
Braiteh, Fadi ;
Grilley-Olson, Juneko E. ;
Wang, Xiao ;
Forgie, Alison ;
Bonato, Vinicius ;
Jacobs, Ira A. ;
Chou, Jeffrey ;
Johnson, Melissa L. .
TARGETED ONCOLOGY, 2021, 16 (06) :773-787
[50]   Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration [J].
Siwen Hu-Lieskovan ;
Fadi Braiteh ;
Juneko E. Grilley-Olson ;
Xiao Wang ;
Alison Forgie ;
Vinicius Bonato ;
Ira A. Jacobs ;
Jeffrey Chou ;
Melissa L. Johnson .
Targeted Oncology, 2021, 16 :773-787
12345